| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
9,599 |
8,869 |
$852K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,321 |
2,766 |
$242K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,998 |
2,418 |
$217K |
| 92134 |
|
4,518 |
4,096 |
$120K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,730 |
1,480 |
$99K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,508 |
1,321 |
$91K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
670 |
635 |
$89K |
| 92083 |
|
1,389 |
1,253 |
$55K |
| 92250 |
|
2,008 |
1,807 |
$54K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
138 |
134 |
$47K |
| 92133 |
|
1,649 |
1,464 |
$39K |
| J9035 |
Injection, bevacizumab, 10 mg |
741 |
663 |
$38K |
| 92015 |
Determination of refractive state |
1,285 |
1,230 |
$34K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
138 |
121 |
$16K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
31 |
30 |
$13K |
| J3590 |
Unclassified biologics |
343 |
263 |
$12K |
| 92226 |
|
308 |
174 |
$7K |
| 92235 |
|
83 |
80 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
51 |
41 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
81 |
73 |
$3K |
| 92136 |
|
169 |
142 |
$3K |
| J7999 |
Compounded drug, not otherwise classified |
164 |
137 |
$2K |
| 92002 |
|
12 |
12 |
$940.40 |
| 92225 |
|
22 |
12 |
$636.20 |
| 76514 |
|
61 |
51 |
$432.08 |